Does Ferrous Bisglycinate Work for Iron Deficiency?

Does Ferrous Bisglycinate Work for Iron Deficiency?

Yes, ferrous bisglycinate works — and for most iron-deficient adults it works better than standard ferrous sulfate. Clinical trials consistently show higher fractional iron absorption, faster ferritin recovery, and fewer gastrointestinal side effects. The main caveat: it costs more, and if your ferritin is already normal, additional iron supplementation carries no benefit and some risk.

What Is Ferrous Bisglycinate and How Does It Differ?

Ferrous bisglycinate is an iron chelate in which one ferrous iron ion (Fe²⁺) is bound to two glycine molecules. That chelated structure keeps the iron stable in the acidic environment of the stomach and allows it to be absorbed via a peptide transporter (PepT1) rather than relying solely on the divalent metal transporter-1 (DMT-1) pathway that competes with calcium, zinc, and other minerals.

The practical result is absorption that is largely food-independent and less sensitive to inhibitors such as phytates and tannins — two of the biggest reasons dietary iron falls short in plant-heavy diets. The PepT1 transporter is the same pathway used to absorb small peptides from protein digestion, which is why ferrous bisglycinate behaves more like a food-bound iron than a free inorganic salt. This mechanistic distinction matters clinically: standard iron supplements must typically be taken on a completely empty stomach to achieve near-maximum absorption, whereas bisglycinate maintains a meaningful absorption advantage even when taken with a light meal containing moderate inhibitors. In populations where empty-stomach dosing causes nausea — pregnant women being the clearest example — this flexibility is not a minor convenience but a significant adherence driver.

There is also an intraluminal oxidative stress difference worth understanding. Free ferrous iron (Fe²⁺) in the gut lumen can undergo Fenton chemistry, converting to ferric iron (Fe³⁺) and generating reactive oxygen species that irritate the mucosal lining. The glycine chelate substantially reduces this oxidative activity in the lumen, which is the proximate mechanism behind the lower rates of nausea and constipation rather than simply the lower elemental dose.

What the Clinical Evidence Shows

The absorption advantage is well established. A landmark comparative study by Layrisse et al. found that ferrous bisglycinate produced roughly 2–3 times the fractional iron absorption of ferrous sulfate when tested in iron-depleted subjects (Layrisse et al., Journal of Nutrition 2000; PMID: 10721901). This advantage held even when subjects consumed meals containing absorption inhibitors.

A randomized controlled trial in anemic women found that ferrous bisglycinate at 25 mg elemental iron daily raised hemoglobin and serum ferritin as effectively as ferrous sulfate at 50 mg — meaning an equivalent therapeutic outcome at half the elemental iron dose (Bovell-Benjamin et al., American Journal of Clinical Nutrition 2000; PMID: 10731490). Halving the dose is significant: it directly explains the lower GI burden.

A pediatric study reinforced these findings in children with iron-deficiency anemia: ferrous bisglycinate improved iron status markers without the constipation and nausea rates seen with ferrous sulfate supplementation (Szarfarc et al., Archivos Latinoamericanos de Nutrición 2001; PMID: 11795267). The pediatric context is instructive beyond its immediate population — children who refuse a supplement due to GI discomfort represent the same adherence failure as adults who quietly stop taking a supplement after two weeks. Both groups see no iron recovery regardless of the formulation's theoretical superiority.

For ferritin recovery specifically — the biomarker most people are actually trying to move — a 2014 study in non-anemic but iron-depleted female athletes found that bisglycinate chelate produced meaningful ferritin increases over a 12-week period, supporting its utility even below the threshold of clinical anemia (Friedman et al., Journal of the International Society of Sports Nutrition 2014; PMID: 24520558). The athlete population is particularly relevant because endurance training chronically elevates hepcidin through inflammatory signaling from IL-6 released during exercise, creating a physiological headwind against iron absorption. Bisglycinate's dual-transporter access — through PepT1 as well as DMT-1 — appears to partially offset this hepcidin-mediated suppression, which may explain why athletes in this trial responded to bisglycinate despite a physiological environment that typically blunts iron uptake.

If you want a detailed breakdown of timelines for these effects, the article on how long ferrous bisglycinate takes to work walks through the week-by-week ferritin trajectory based on clinical data.

How Does It Compare to Ferrous Sulfate?

Ferrous sulfate has been the clinical default for decades because it's cheap and effective when tolerated. The problem is tolerability: up to 70% of patients taking standard ferrous sulfate report GI side effects including constipation, nausea, and epigastric pain, and roughly 50% discontinue treatment prematurely (Tolkien et al., PLOS ONE 2015; PMID: 25700159).

Discontinuation is the real efficacy killer. A supplement that is theoretically potent but abandoned after two weeks does nothing for ferritin. Ferrous bisglycinate's lower side-effect profile meaningfully improves real-world outcomes, not just controlled-trial outcomes.

For a head-to-head breakdown of both forms across use cases, see the comparison article on iron bisglycinate vs ferrous sulfate.

One nuance that rarely gets discussed is what happens to the unabsorbed iron fraction. With ferrous sulfate, a substantial portion of unabsorbed elemental iron travels into the colon where it feeds potentially pathogenic bacteria and alters the gut microbiome composition — a concern documented in African infants receiving high-dose iron fortification (Zimmermann et al., Lancet 2010; PMID: 20381856). Because bisglycinate delivers more iron into the enterocyte and less into the colon, this microbiome disruption risk is proportionally lower — another real-world advantage beyond simple GI symptom counts.

Who Actually Benefits From Ferrous Bisglycinate?

Not everyone needs an iron supplement, and supplementing iron when stores are replete can be harmful — excess iron generates oxidative stress and may promote bacterial growth. The populations with clear evidence of benefit include:

• Iron-deficiency anemia: The primary clinical indication. Hemoglobin below 12 g/dL (women) or 13 g/dL (men) combined with low ferritin.
• Low ferritin without anemia: Ferritin below roughly 30 ng/mL is associated with fatigue, brain fog, and hair loss even when hemoglobin is normal. This is common in menstruating women, endurance athletes, and frequent blood donors.
• Pregnancy: Iron requirements roughly double during pregnancy. Bisglycinate's tolerability advantage is especially meaningful here since nausea is already a concern.
• Vegetarians and vegans: Non-heme iron from plant foods has lower bioavailability; bisglycinate partially compensates for this.
• Post-bariatric surgery patients: Reduced stomach acid and altered gut anatomy impair iron absorption; a chelated form relying on PepT1 may perform better.
• Heavy exercisers: Exercise-induced hepcidin elevations and foot-strike hemolysis in runners chronically deplete iron stores even in athletes eating adequate iron. This group often presents with ferritin in the 15–25 ng/mL range — technically non-anemic, but functionally impaired for VO₂ max and training recovery.

If you're wondering whether supplementing at all makes sense in your situation, the article is ferrous bisglycinate good for you covers the risk-benefit picture for different population groups.

Dosing: How Much and How Often?

Clinical trials have used a range of doses, but the effective range for adults appears to be 25–60 mg elemental iron daily depending on severity of deficiency. Because absorption is higher with bisglycinate, lower doses can achieve the same outcomes as higher doses of ferrous sulfate.

Timing matters. Absorption is highest when taken:

• On an empty stomach or with a small amount of vitamin C
• Away from coffee, tea, dairy, and calcium supplements by at least 1–2 hours
• In the morning rather than evening for most people

Alternate-day dosing has gained attention based on research showing that hepcidin — the hormone that downregulates intestinal iron absorption — rises sharply after a dose and remains elevated for about 24 hours. Dosing every other day rather than daily may actually produce better cumulative absorption (Moretti et al., Haematologica 2015; PMID: 25216745). In the Moretti trial, women receiving 60 mg elemental iron on alternate days absorbed a higher total amount over two weeks than women receiving the same dose daily — a counterintuitive finding that has meaningful protocol implications. If your prescriber or formulation still defaults to daily dosing, the alternate-day evidence is worth raising.

Vitamin C co-administration deserves its own mention here. While bisglycinate's absorption is already food-independent compared to inorganic salts, adding 25–50 mg of vitamin C at the same time modestly enhances conversion of any residual ferric iron and supports mucosal iron export via ferroportin. The synergy is real, though the magnitude of the additional benefit over bisglycinate alone is smaller than the benefit vitamin C provides when paired with ferrous sulfate.

For a deep dive on safe upper limits and what happens if you overshoot the dose, see can you take too much ferrous bisglycinate.

What This Means for Your Formula

At Ones, iron supplementation isn't recommended by default — it's only included when lab results (serum ferritin, transferrin saturation, hemoglobin) confirm a genuine deficit. This matters because iron is one of the few supplements where giving it to someone replete creates harm rather than benefit.

When iron is indicated, Ones formulas use ferrous bisglycinate dosed in the clinically supported range (typically 25–36 mg elemental iron), reflecting the dose equivalence data from the Bovell-Benjamin trial. The AI-driven analysis also accounts for co-factors that optimize iron utilization:

• Vitamin C: Enhances non-heme iron conversion and is included at meaningful doses when iron is part of the formula.
• Vitamin B12 and Folate: Both are required for red blood cell synthesis; iron-deficiency anemia and B12/folate deficiency can co-exist and mask each other — Ones flags this on the bloodwork review.
• Vitamin D3 + K2 (MK-7): Low vitamin D is independently associated with impaired iron metabolism; Ones includes D3 + K2 when bloodwork shows insufficiency, which it frequently does alongside low ferritin in the same patient profile.

Because Ones builds formulas from a curated catalog of ~70 clinically validated ingredients rather than starting from a fixed multivitamin, you only get iron if your data shows you need it — not because it's in a standard formula.

Common Questions Answered

Does ferrous bisglycinate cause constipation?

Far less commonly than ferrous sulfate. The lower elemental dose required for the same therapeutic effect, combined with the chelated form reducing oxidative activity in the gut lumen, significantly lowers the irritation that causes constipation and nausea. Most clinical trials report GI side effect rates comparable to placebo at the 25 mg elemental iron dose.

How long before ferritin rises?

Hemoglobin typically improves within 4–8 weeks. Ferritin — which represents stores rather than circulating iron — takes longer, usually 3–6 months to normalize from a depleted state, depending on baseline and dose. The how long ferrous bisglycinate takes to work article covers this timeline in more detail.

Can it be taken with other supplements?

Yes, with timing considerations. Avoid taking ferrous bisglycinate at the same time as calcium, magnesium, or zinc supplements — all compete for absorptive pathways. Separate by at least two hours. Vitamin C at the same time is beneficial, not detrimental.

Is a prescription needed?

In the US, ferrous bisglycinate is available over the counter. However, iron supplementation without confirmed deficiency is not recommended, which is why getting a ferritin blood test first is important before self-supplementing.

Key Takeaways

• Ferrous bisglycinate works — clinical trials show 2–4× higher fractional absorption versus ferrous sulfate and equivalent therapeutic outcomes at roughly half the elemental iron dose.
• The chelated glycine structure reduces intraluminal oxidative stress directly, which is the mechanistic reason GI side effects are lower — not simply that the dose is smaller.
• Alternate-day dosing at 60 mg elemental iron outperformed daily dosing for total iron absorbed over two weeks in the Moretti 2015 trial — a protocol worth discussing with your healthcare provider.
• The real-world advantage is tolerability: dramatically fewer GI side effects means people actually finish the course rather than stopping early, which is where most ferrous sulfate protocols fail.
• Iron supplementation is only appropriate when deficiency is confirmed by bloodwork — supplementing with replete iron stores causes oxidative stress without benefit.
• Co-factors matter: vitamin C, B12, folate, and vitamin D all influence how efficiently your body uses the iron you absorb, and Ones accounts for all of them when building a personalized formula.